Agngarayngay, Baby Boy .

HRN: 28-59-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/18/2026
02/25/2026
IV
30 Mg
Q 36 Hours
PSNB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines